Fatemeh Karimzadeh

Fatemeh Karimzadeh

Auto-generated profile, based on publicly available information

Fatemeh Karimzadeh

Student Research committee, Shahrekord University of Medical Sciences, Shahrekord, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2024 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
FKFatemeh Karimzadeh
Fatemeh Karimzadeh
EFElahe Soltani Fard
Elahe Soltani Fard
ANAkram Nadi
Akram Nadi
RMRahim Malekzadeh
Rahim Malekzadeh
FEFatemeh Elahian
Fatemeh Elahian
SMSeyed Abbas Mirzaei
Seyed Abbas Mirzaei
Gene-activated matrices are versatile and novel technologies to treat skin wounds. This approach offers a promising avenue for targeted treatment strategies in skin health care.

3 March 2025 in Advanced Materials Technologies
Verified
Journal Article
Closed access
ANAkram Nadi
Akram Nadi
EFElahe Soltani Fard
Elahe Soltani Fard
FKFatemeh Karimzadeh
Fatemeh Karimzadeh
FEFatemeh Elahian
Fatemeh Elahian
SMSeyed Abbas Mirzaei
Seyed Abbas Mirzaei

8 December 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FKFatemeh Karimzadeh
Fatemeh Karimzadeh
RHRazieh Heidari
Razieh Heidari
FLFatemeh Mahmoudi Lamooki
Fatemeh Mahmoudi Lamooki
ESEhsan Heidari Soureshjani
Ehsan Heidari Soureshjani
Shahkaar AzizShahkaar Aziz
Shahkaar Aziz
SMSeyed Abbas Mirzaei
Seyed Abbas Mirzaei
The increasing prevalence of gastrointestinal infections caused by Cryptosporidium parvum and Schistosoma mansoni, coupled with the lack of definitive treatments, underscores the need for vaccine development to prevent infection-related cancers. Using experimentally validated epitopes for vaccine development enhances confidence in inducing strong and durable immune responses compared to predicted epitopes, which require lab validation. In this study, we employed a unique computational strategy using 197 experimentally validated epitopes of C. parvum and S. mansoni obtained from the IEDB database. After applying homology filters against human proteome and microbiome sequences and conducting HLA population coverage analysis, we chose seven cytotoxic T lymphocyte (CTL), seven helper T cell (HTL), and five B-cell epitopes. These were combined with an RpfE adjuvant and appropriate linkers to design a highly immunogenic chimeric antigen with broad global coverage, optimized for stability, solubility, and manufacturability. Molecular docking revealed strong binding affinities of CTL and HTL epitopes to their respective HLA alleles. Immune simulations demonstrated the multi-epitope antigen’s ability to elicit both innate and adaptive immune responses. Docking of the vaccine construct with immune receptors (TLR2-TLR1 and TLR4-MD2) yielded significant scores of − 179.8 ± 4.5 and − 191.5 ± 3.4 kcal/mol, respectively. Molecular dynamics simulations verified the structural stability of vaccine–receptor complexes, while binding free energy calculations reinforced their strong affinities. Finally, in silico cloning validated the vaccine’s potential for efficient E. coli expression. These computational findings support the construct as a promising vaccine candidate against C. parvum and S. mansoni, warranting further experimental validation.

29 May 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
FKFatemeh Karimzadeh
Fatemeh Karimzadeh
KMKarim Mahnam
Karim Mahnam
MRMehdi Rezaee
Mehdi Rezaee
FTFatemeh Toghroli
Fatemeh Toghroli
RMRahim Malekzadeh
Rahim Malekzadeh
SMSeyed Abbas Mirzaei
Seyed Abbas Mirzaei

28 October 2025 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
RMRahim Malekzadeh
Rahim Malekzadeh
KMKarim Mahnam
Karim Mahnam
FKFatemeh Karimzadeh
Fatemeh Karimzadeh
MBMobina Bahadorani
Mobina Bahadorani
MRMehdi Rezaee
Mehdi Rezaee
SMSeyed Abbas Mirzaei
Seyed Abbas Mirzaei

13 April 2026 in Polymers for Advanced Technologies
Verified
Journal Article
Closed access
ANAkram Nadi
Akram Nadi
RMRahim Malekzadeh
Rahim Malekzadeh
FKFatemeh Karimzadeh
Fatemeh Karimzadeh
EFElahe Soltani Fard
Elahe Soltani Fard
SHSeyed Masih Hosseini
Seyed Masih Hosseini
SMSeyed Abbas Mirzaei
Seyed Abbas Mirzaei